Dr. William Capo, MD
What this data tells you about Dr. Capo
Dr. William Capo is a cardiovascular disease in Tampa, FL, with 20 years in practice. Based on federal Medicare data, Dr. Capo performed 2,253 Medicare services across 1,329 unique beneficiaries.
Between the years covered by Open Payments, Dr. Capo received a total of $49,007 from 34 pharmaceutical and/or device companies across 395 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Capo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 566 | $89 | $273 |
| Hospital follow-up visit, moderate complexity | 362 | $62 | $186 |
| Regadenoson injection (Lexiscan) for heart stress test | 176 | $43 | $144 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 143 | $27 | $93 |
| Initial hospital admission, moderate complexity | 135 | $103 | $351 |
| Echocardiogram, transthoracic | 120 | $136 | $507 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 108 | $351 | $897 |
| Electrocardiogram (EKG), 12-lead | 105 | $10 | $43 |
| EKG interpretation and report | 78 | $6 | $22 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 69 | $47 | $177 |
| Remote pacemaker/defibrillator monitoring, 90 days | 65 | $17 | $62 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 54 | $327 | $1,178 |
| Heart muscle strain imaging | 50 | $27 | $99 |
| Remote pacemaker monitoring, 90 days | 39 | $23 | $79 |
| Programming of dual lead pacemaker system | 35 | $51 | $162 |
| New patient office visit (45-59 min) | 26 | $117 | $415 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 22 | $124 | $479 |
| Ultrasound of heart with probe in esophagus, with report | 18 | $83 | $280 |
| Cardiac catheterization | 18 | $236 | $807 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 16 | $9 | $37 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 16 | $18 | $62 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $14 | $47 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 16 | $2 | $8 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for cardiovascular disease in FL.
Geographic Context
4.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Capo is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 8%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Capo experienced with office visit, established patient (30-39 min)?
Does Dr. Capo receive payments from pharmaceutical companies?
How do Dr. Capo's costs compare to other cardiovascular diseases in Tampa?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology